Results of Functional Treatment of Epi-Metaphyseal Fractures of the Base of the Fifth Metatarsal.


Journal

Foot & ankle international
ISSN: 1944-7876
Titre abrégé: Foot Ankle Int
Pays: United States
ID NLM: 9433869

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 27 2 2020
medline: 1 9 2021
entrez: 27 2 2020
Statut: ppublish

Résumé

Fractures of the fifth metatarsal base (5th MT) are common foot injuries, but their treatment remains a subject of debate. The aim was to assess the midterm outcome of functionally treated epi-metaphyseal fractures (Lawrence and Botte types I and II) of the 5th MT. This study was a longitudinal retrospective database study with prospective follow-up. Included were all patients with an acute, isolated fracture to the 5th MT base (types I and II). All patients were treated functionally: weightbearing as tolerated without immobilization. Fracture types and fracture characteristics (displacement <2 mm/>2 mm, articular involvement, number of fragments) were assessed retrospectively. Patient-reported outcome measures (PROMs) including the visual analog scale for foot and ankle (VAS FA) and the quality-of-life score (QoL) SF-12 were collected prospectively at 2- and 5-year follow-up. Out of 95 patients, 43 patients (45%) were included with a median follow-up of 5.7 (1.5) years. For both the VAS FA and SF-12, excellent scores were observed. For 30 patients (77%), longitudinal 2- and 5-year follow-up was available. No significant longitudinal changes could be observed for the VAS FA and SF-12. For both time points, neither fracture type nor characteristics significantly influenced any outcome parameter assessed. Functional treatment by full weightbearing and free range of motion led to excellent 5-year results for both type I and II fractures. Neither fracture location nor characteristics had a significant influence on the 5-year PROMs. Level III, comparative study.

Sections du résumé

BACKGROUND
Fractures of the fifth metatarsal base (5th MT) are common foot injuries, but their treatment remains a subject of debate. The aim was to assess the midterm outcome of functionally treated epi-metaphyseal fractures (Lawrence and Botte types I and II) of the 5th MT.
METHODS
This study was a longitudinal retrospective database study with prospective follow-up. Included were all patients with an acute, isolated fracture to the 5th MT base (types I and II). All patients were treated functionally: weightbearing as tolerated without immobilization. Fracture types and fracture characteristics (displacement <2 mm/>2 mm, articular involvement, number of fragments) were assessed retrospectively. Patient-reported outcome measures (PROMs) including the visual analog scale for foot and ankle (VAS FA) and the quality-of-life score (QoL) SF-12 were collected prospectively at 2- and 5-year follow-up. Out of 95 patients, 43 patients (45%) were included with a median follow-up of 5.7 (1.5) years.
RESULTS
For both the VAS FA and SF-12, excellent scores were observed. For 30 patients (77%), longitudinal 2- and 5-year follow-up was available. No significant longitudinal changes could be observed for the VAS FA and SF-12. For both time points, neither fracture type nor characteristics significantly influenced any outcome parameter assessed.
CONCLUSION
Functional treatment by full weightbearing and free range of motion led to excellent 5-year results for both type I and II fractures. Neither fracture location nor characteristics had a significant influence on the 5-year PROMs.
LEVEL OF EVIDENCE
Level III, comparative study.

Identifiants

pubmed: 32100555
doi: 10.1177/1071100720907391
pmc: PMC7294529
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

666-673

Références

Bone Joint J. 2016 Jun;98-B(6):806-11
pubmed: 27235524
Foot Ankle Spec. 2015 Oct;8(5):354-9
pubmed: 25666689
Injury. 2015 Aug;46(8):1664-8
pubmed: 26052051
J Orthop Surg (Hong Kong). 2018 Jan-Apr;26(1):2309499017747128
pubmed: 29228848
Foot Ankle Int. 2005 Sep;26(9):704-7
pubmed: 16174500
Unfallchirurg. 2018 Sep;121(9):723-729
pubmed: 29777283
Swiss Surg. 1997;3(2):81-4
pubmed: 9190283
Injury. 2010 Jun;41(6):555-62
pubmed: 19570536
Foot Ankle Int. 2007 May;28(5):581-3
pubmed: 17559765
Am J Sports Med. 2005 Jul;33(7):970-5
pubmed: 15888715
Iran J Med Sci. 2015 Mar;40(2):104-9
pubmed: 25821289
Rev Med Suisse. 2007 Aug 2;3(120):1792-4
pubmed: 17850008
J Foot Ankle Surg. 2018 Sep - Oct;57(5):982-986
pubmed: 30149851
Ther Adv Musculoskelet Dis. 2018 Apr;10(4):91-103
pubmed: 29619094
Skeletal Radiol. 2014 Apr;43(4):467-74
pubmed: 24442562
Foot Ankle Int. 1997 May;18(5):267-9
pubmed: 9167925
Foot Ankle Int. 2013 Jan;34(1):75-9
pubmed: 23386764
Foot Ankle Int. 2016 May;37(5):488-500
pubmed: 26781131
Unfallchirurg. 2008 Oct;111(10):829-39; quiz 840
pubmed: 18820889
Arch Orthop Trauma Surg. 2011 Feb;131(2):241-5
pubmed: 20714904
Clin Pharmacol Ther. 2016 Oct;100(4):353-61
pubmed: 27393601
Arch Trauma Res. 2016 Jun 13;5(4):e33298
pubmed: 28144601
BMC Musculoskelet Disord. 2017 Dec 16;18(1):534
pubmed: 29246170
Foot Ankle. 1993 Jul-Aug;14(6):358-65
pubmed: 8406253
Injury. 2014 Dec;45(12):2009-12
pubmed: 25150752
Eur J Trauma Emerg Surg. 2018 Oct;44(5):727-734
pubmed: 29026929
Int Orthop. 2007 Feb;31(1):5-10
pubmed: 16721621
Foot Ankle Int. 2002 May;23(5):440-6
pubmed: 12043990
Clin Sports Med. 2006 Jan;25(1):139-50, x
pubmed: 16324980
Foot Ankle Surg. 2013 Dec;19(4):207-11
pubmed: 24095225
Foot Ankle Surg. 2011 Dec;17(4):300-7
pubmed: 22017907
Injury. 2012 Oct;43(10):1626-32
pubmed: 22465516
Foot Ankle Surg. 2011 Sep;17(3):166-72
pubmed: 21783078

Auteurs

Sebastian F Baumbach (SF)

Department of General, Trauma and Reconstructive Surgery, University Hospital, LMU Munich, Munich, Germany.

Marcel Urresti-Gundlach (M)

Department of General, Trauma and Reconstructive Surgery, University Hospital, LMU Munich, Munich, Germany.

Wolfgang Böcker (W)

Department of General, Trauma and Reconstructive Surgery, University Hospital, LMU Munich, Munich, Germany.

J Turner Vosseller (JT)

Department of Orthopaedic Surgery, Columbia University Medical Center, New York, NY, USA.

Hans Polzer (H)

Department of General, Trauma and Reconstructive Surgery, University Hospital, LMU Munich, Munich, Germany.
Department of Orthopaedic Surgery, Columbia University Medical Center, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH